EMA Information Day on Services and Systems in Pharmacovigilance

This event will provide marketing-authorisation holders with information on the development of the enhanced systems, helping them prepare for the business change to come.

Back to Agenda

Session 3: EMA Service of Medical Literature Monitoring for Reports of Suspected Adverse Drug Reactions

Session Chair(s)

Sabine Brosch, PHARMD, PHD, MPHARM

Data Protection Officer, European Medicines Agency, Netherlands

Margaret Anne Walters

Deputy EU Qualified Person for Pharmacovigilance, Merck, Sharp & Dohme Ltd, United Kingdom

This session will focus on the recently launched medical literature monitoring service including the impact of the EMA medical literature service on the NCAs’ and pharmaceutical companies’ business processes and experience to date.

Speaker(s)

Tom Paternoster-Howe, MSC

Scientific Administrator, Data Analytics & Methods, Task Force, Healthcare Data, European Medicines Agency, Netherlands

How the Service Works and Experience to Date

Murielle Musset, PHD

Literature Surveillance Team Lead (Pharmacovigilance), Sanofi, France

Industry Experience and Feedback

Have an account?